vs

Side-by-side financial comparison of Organogenesis Holdings Inc. (ORGO) and Strategic Education, Inc. (STRA). Click either name above to swap in a different company.

Strategic Education, Inc. is the larger business by last-quarter revenue ($305.9M vs $225.6M, roughly 1.4× Organogenesis Holdings Inc.). Organogenesis Holdings Inc. runs the higher net margin — 19.4% vs 10.7%, a 8.6% gap on every dollar of revenue. On growth, Organogenesis Holdings Inc. posted the faster year-over-year revenue change (78.1% vs 0.8%). Strategic Education, Inc. produced more free cash flow last quarter ($77.3M vs $34.8M). Over the past eight quarters, Organogenesis Holdings Inc.'s revenue compounded faster (43.2% CAGR vs -1.0%).

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

Strategic Education, Inc. (SEI) is an education services holding company and is formerly known as Strayer Education, Inc. The company owns for-profit, online Capella University and Strayer University, as well as non-degree programs schools such as DevMountain, Hackbright Academy, and Sophia Learning.

ORGO vs STRA — Head-to-Head

Bigger by revenue
STRA
STRA
1.4× larger
STRA
$305.9M
$225.6M
ORGO
Growing faster (revenue YoY)
ORGO
ORGO
+77.4% gap
ORGO
78.1%
0.8%
STRA
Higher net margin
ORGO
ORGO
8.6% more per $
ORGO
19.4%
10.7%
STRA
More free cash flow
STRA
STRA
$42.5M more FCF
STRA
$77.3M
$34.8M
ORGO
Faster 2-yr revenue CAGR
ORGO
ORGO
Annualised
ORGO
43.2%
-1.0%
STRA

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ORGO
ORGO
STRA
STRA
Revenue
$225.6M
$305.9M
Net Profit
$43.7M
$32.8M
Gross Margin
Operating Margin
28.1%
13.4%
Net Margin
19.4%
10.7%
Revenue YoY
78.1%
0.8%
Net Profit YoY
469.5%
10.3%
EPS (diluted)
$0.31
$1.48

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ORGO
ORGO
STRA
STRA
Q1 26
$305.9M
Q4 25
$225.6M
$323.2M
Q3 25
$150.9M
$319.9M
Q2 25
$101.0M
$321.5M
Q1 25
$86.7M
$303.6M
Q4 24
$126.7M
$311.5M
Q3 24
$115.2M
$306.0M
Q2 24
$130.2M
$312.3M
Net Profit
ORGO
ORGO
STRA
STRA
Q1 26
$32.8M
Q4 25
$43.7M
$37.9M
Q3 25
$21.6M
$26.6M
Q2 25
$-9.4M
$32.3M
Q1 25
$-18.8M
$29.7M
Q4 24
$7.7M
$25.3M
Q3 24
$12.3M
$27.7M
Q2 24
$-17.0M
$29.9M
Gross Margin
ORGO
ORGO
STRA
STRA
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Operating Margin
ORGO
ORGO
STRA
STRA
Q1 26
13.4%
Q4 25
28.1%
16.0%
Q3 25
13.7%
11.6%
Q2 25
-12.5%
14.2%
Q1 25
-30.9%
13.1%
Q4 24
8.1%
11.6%
Q3 24
5.4%
11.9%
Q2 24
-10.7%
13.4%
Net Margin
ORGO
ORGO
STRA
STRA
Q1 26
10.7%
Q4 25
19.4%
11.7%
Q3 25
14.3%
8.3%
Q2 25
-9.3%
10.1%
Q1 25
-21.7%
9.8%
Q4 24
6.1%
8.1%
Q3 24
10.7%
9.1%
Q2 24
-13.1%
9.6%
EPS (diluted)
ORGO
ORGO
STRA
STRA
Q1 26
$1.48
Q4 25
$0.31
$1.65
Q3 25
$0.11
$1.15
Q2 25
$-0.10
$1.37
Q1 25
$-0.17
$1.24
Q4 24
$0.05
$1.05
Q3 24
$0.09
$1.15
Q2 24
$-0.13
$1.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ORGO
ORGO
STRA
STRA
Cash + ST InvestmentsLiquidity on hand
$93.7M
$150.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$300.1M
$1.6B
Total Assets
$598.7M
$2.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ORGO
ORGO
STRA
STRA
Q1 26
$150.3M
Q4 25
$93.7M
$148.1M
Q3 25
$63.7M
$172.6M
Q2 25
$73.1M
$164.9M
Q1 25
$110.0M
$182.6M
Q4 24
$135.6M
$184.0M
Q3 24
$94.3M
$222.1M
Q2 24
$89.9M
$256.2M
Total Debt
ORGO
ORGO
STRA
STRA
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Stockholders' Equity
ORGO
ORGO
STRA
STRA
Q1 26
$1.6B
Q4 25
$300.1M
$1.6B
Q3 25
$255.1M
$1.7B
Q2 25
$233.2M
$1.7B
Q1 25
$242.9M
$1.6B
Q4 24
$262.9M
$1.7B
Q3 24
$278.5M
$1.7B
Q2 24
$263.5M
$1.7B
Total Assets
ORGO
ORGO
STRA
STRA
Q1 26
$2.1B
Q4 25
$598.7M
$2.0B
Q3 25
$509.8M
$2.1B
Q2 25
$461.1M
$2.1B
Q1 25
$467.4M
$2.1B
Q4 24
$497.9M
$2.0B
Q3 24
$446.3M
$2.2B
Q2 24
$443.2M
$2.2B
Debt / Equity
ORGO
ORGO
STRA
STRA
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ORGO
ORGO
STRA
STRA
Operating Cash FlowLast quarter
$39.4M
$87.4M
Free Cash FlowOCF − Capex
$34.8M
$77.3M
FCF MarginFCF / Revenue
15.4%
25.3%
Capex IntensityCapex / Revenue
2.1%
Cash ConversionOCF / Net Profit
0.90×
2.66×
TTM Free Cash FlowTrailing 4 quarters
$-24.5M
$173.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ORGO
ORGO
STRA
STRA
Q1 26
$87.4M
Q4 25
$39.4M
$39.2M
Q3 25
$3.1M
$60.1M
Q2 25
$-32.9M
$31.2M
Q1 25
$-19.9M
$67.7M
Q4 24
$10.9M
$15.9M
Q3 24
$8.7M
$51.5M
Q2 24
$4.7M
$24.3M
Free Cash Flow
ORGO
ORGO
STRA
STRA
Q1 26
$77.3M
Q4 25
$34.8M
$27.0M
Q3 25
$844.0K
$49.3M
Q2 25
$-36.5M
$20.4M
Q1 25
$-23.6M
$57.3M
Q4 24
$7.6M
$4.7M
Q3 24
$6.1M
$42.1M
Q2 24
$2.9M
$13.6M
FCF Margin
ORGO
ORGO
STRA
STRA
Q1 26
25.3%
Q4 25
15.4%
8.3%
Q3 25
0.6%
15.4%
Q2 25
-36.1%
6.3%
Q1 25
-27.2%
18.9%
Q4 24
6.0%
1.5%
Q3 24
5.3%
13.8%
Q2 24
2.2%
4.3%
Capex Intensity
ORGO
ORGO
STRA
STRA
Q1 26
Q4 25
2.1%
3.8%
Q3 25
1.5%
3.4%
Q2 25
3.6%
3.4%
Q1 25
4.2%
3.4%
Q4 24
2.7%
3.6%
Q3 24
2.2%
3.1%
Q2 24
1.4%
3.4%
Cash Conversion
ORGO
ORGO
STRA
STRA
Q1 26
2.66×
Q4 25
0.90×
1.03×
Q3 25
0.14×
2.26×
Q2 25
0.97×
Q1 25
2.27×
Q4 24
1.43×
0.63×
Q3 24
0.71×
1.86×
Q2 24
0.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ORGO
ORGO

Segment breakdown not available.

STRA
STRA

U.S. Higher Education$212.6M69%
Australia/New Zealand$51.8M17%
Education Technology Services$41.5M14%

Related Comparisons